Edap TMS SA (EDAP)
6.71
-0.18
(-2.61%)
USD |
NASDAQ |
May 17, 16:00
6.79
+0.08
(+1.19%)
After-Hours: 20:00
Edap TMS SG&A Expense (Quarterly): 10.60M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.60M |
| September 30, 2023 | 8.804M |
| June 30, 2023 | 8.945M |
| March 31, 2023 | 11.95M |
| December 31, 2022 | 7.652M |
| September 30, 2022 | 5.848M |
| June 30, 2022 | 5.810M |
| March 31, 2022 | 5.372M |
| December 31, 2021 | 5.934M |
| September 30, 2021 | 5.242M |
| June 30, 2021 | 4.481M |
| March 31, 2021 | 3.954M |
| December 31, 2020 | 4.615M |
| September 30, 2020 | 3.704M |
| June 30, 2020 | 3.410M |
| March 31, 2020 | 3.840M |
| December 31, 2019 | 4.670M |
| September 30, 2019 | 3.916M |
| June 30, 2019 | 4.146M |
| March 31, 2019 | 4.139M |
| December 31, 2018 | 2.594M |
| September 30, 2018 | 11.58M |
| June 30, 2018 | 4.097M |
| March 31, 2018 | 4.193M |
| December 31, 2017 | 4.137M |
| Date | Value |
|---|---|
| September 30, 2017 | 3.396M |
| June 30, 2017 | 3.826M |
| March 31, 2017 | 3.276M |
| December 31, 2016 | 4.028M |
| September 30, 2016 | 3.074M |
| June 30, 2016 | 3.298M |
| March 31, 2016 | 3.028M |
| December 31, 2015 | 3.444M |
| September 30, 2015 | 2.469M |
| June 30, 2015 | 3.104M |
| March 31, 2015 | 2.741M |
| December 31, 2014 | 3.569M |
| September 30, 2014 | 3.118M |
| June 30, 2014 | 3.396M |
| March 31, 2014 | 3.178M |
| December 31, 2013 | 3.343M |
| September 30, 2013 | 2.819M |
| June 30, 2013 | 3.187M |
| March 31, 2013 | 3.242M |
| December 31, 2012 | 3.844M |
| September 30, 2012 | 2.707M |
| June 30, 2012 | 3.179M |
| March 31, 2012 | 2.884M |
| December 31, 2011 | 3.476M |
| September 30, 2011 | 2.955M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
3.410M
Minimum
Jun 2020
11.95M
Maximum
Mar 2023
5.942M
Average
5.242M
Median
Sep 2021
SG&A Expense (Quarterly) Benchmarks
| Biophytis SA | -- |
| Cellectis SA | 4.671M |
| DBV Technologies SA | 6.428M |
| Genfit SA | -- |
| Biodexa Pharmaceuticals Plc | -- |